Analysts' ratings for Health Catalyst (NASDAQ:HCAT) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 5 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 2 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.0, a high estimate of $16.00, and a low estimate of $7.00. Highlighting a 7.69% decrease, the current average has fallen from the previous average price target of $13.00.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive Health Catalyst is derived...
Login or create a forever free account to read this news
Sign up/Log in